Wyss Zurich

The latest research findings on the regeneration of spinal cord of paraplegics was just published #OpenAccess by The Lancet Neurology. ✨ The #Therapy treatment, NG101, used in this placebo-controlled study, part of a Phase 2b clinical trial, stems from years of research conducted by Swiss neurologist from the University of Zurich, Prof. Martin Schwab. The therapy was previously accelerated and supported by Wyss Zurich between 2016 and 2022 under the project known as CeNeReg. From the study, NG101 has evidenced its ability to neutralize the growth-inhibiting protein Nogo-A, on recovery in patients with acute cervical traumatic spinal cord injury. The study, co-initiated and organized by Prof. Schwab and Prof. Armin Curt from Universitätsklinik Balgrist involved close to 130 patients and was executed in 13 different clinics across the Europe, including Switzerland, Germany, Czech Republic and Spain. Learn more about the study 👉 https://buff.ly/3BNJkaR #AntibodyTherapy #RegenerativeMedicine #SpinalCordRegeneration #BiotechInnovation #HealthcareAdvancements #NeuroscienceResearch #TherapeuticDevelopment #FutureOfMedicine

✨ Wyss Zurich Christmas Apero 2024 ✨ The magical time of the year is here and we celebrated this spirit at our office🎄. Over a sumptuous spread of cut cheese, meats, wraps amongst others, the Wyss Zurich Family came together to reconnect, celebrate teams and successes and reflect on the year. 💫 Today being one week until Christmas, we wish all our colleagues, supporters, collaborators and stakeholders a wonderful festive and holiday season and looking forward to an eventful 2025!🌟 #MerryChristmas #SeasonsGreetings #HappyNewYear

Not too long ago, we welcomed Joanne Sieber and her team at Deep Tech Nation Switzerland 💫 To understand the first-hand experiences of startup founders in #DeepTech, some of our projects had the opportunity to share not only about their highly innovative technologies and solutions, but also about their journeys in fundraising and the obstacles they foresee and are facing. Projects that presented (current & alumni): 🟢 Waldemar Hoffmann, Liver4Life (aka Apersys AG) 🟢 Deana Mohr-Haralampieva, MUVON (aka MUVON Therapeutics AG) 🟢 Matt Curran, Nanoflex (Nanoflex Robotics ) 🟢 Jonas Wüst, Tethys (Tethys Robotics) 🟢 Simone Bottan, Hylomorph Quick recap of the learning points from the meeting 👉 https://buff.ly/49DAI3e Cultural differences in startup financing between Switzerland and the USA were a pertinent point raised during the discussion. Many startup founders need to look outside of Switzerland, particularly the US, for funding because there are only a handful of Swiss-based VCs that are able and willing to take that risk. 🤔 With that in mind, we're looking forward to how Deep Tech Nation Switzerland will push and transform the boundaries of the existing framework for Swiss start-ups, scale-ups, and investors in the deep tech sector ✨ #DeepTechInnovation #CompetitiveEdge #StartupEcosystem #InnovationFramework #FutureOfTechnology #InnovationLeadership

Such fantastic news to close 2024! Congratulations, Péter Fankhauser and the ANYbotics team 🙌 The team has recently successfully raised $60 million that will support its global scaling efforts and expansion activities in the USA (also with the recent opening of its San Francisco office). The financing round was led by Qualcomm Ventures and Supernova Invest, with new investor TDK Ventures coming onboard, alongside existing supporters. Looking forward to the upgrades to #ANYmal and how the latest technologies in AI and sensors will transform the industrial inspection robot capabilities ✨ ANYbotics (formerly known as ANYmotion) previously accelerated with us at Wyss Zurich to develop and hone its robotic technology. We're incredibly proud of how far #ANYmal and the entire team has come and excited for the next chapters of your journey 😄. Learn more about the financing round below 👇 #startupfinance #startupinvestment #roboticsstartup #roboticsinnovation

🙌 Amazing milestone, Daniela Marino and the CUTISS AG team! We're super excited to see how the Phase 3 clinical trial unfolds. Our alumni project, denovoSkin (now CUTISS AG) recently received authorization from the European Medicines Agency (EMA) to start the clinical trial of their lead product, denovoSkin™. The bio-engineered technology involves a personalized skin tissue therapy, where a healthy piece of skin from a patient can be multiplied via bio-engineering. The goal is improved quality of life for patients requiring skin surgery by reducing the need for follow up and/or corrective surgeries. Learn more about the recent authorization of the Phase 3 clinical trial 👇 #TissueEngineering #BioEngineering #AdvancedTherapies #Biotechnology #StartupInnovation #ClinicalTrials #RegenerativeMedicine

✨ New partnership announcement ✨ Strategic partnership between Wyss Zurich RMTP and ZüriPharm AG to promote innovative therapies The Wyss Zurich Regenerative Medicine Technologies Platform (Wyss Zurich RMTP) of the University of Zurich and ZüriPharm AG are combining their expertise to accelerate the translation of innovative therapies from research to clinical application. The partnership combines Wyss Zurich's expertise in process development and manufacturing of investigational medicinal products with ZüriPharm's focus on industrial GMP production and galenic development. The aim is to cover the entire life cycle of drugs - from research to standard therapies - and to provide patients with rapid access to new therapies. Both partners are thus strengthening Zurich's role as a center of #innovation and creating added value for #science, start-ups and #patients.

Waldemar Hoffmann, project leader of our current project, Liver4Life (aka Apersys AG) will be pitching at the upcoming New England Venture Summit! His team is working on a highly innovative machine to make the regeneration of the human liver outside of the body a possibility for liver transplant patients. To date, the team has managed to increase the viable time of ex situ preservation of whole and partial human livers from a day to an entire week. Learn more 👉 https://lnkd.in/eDjAH--v Interested to learn more about the technology and how you can make an impact for the medical community? Talk to Waldemar to find out how! #InvestorSummit #StartupFinance #VentureCapital #InvestmentOpportunities #Entrepreneurship #FundingInnovation #BusinessNetworking

"My primary aspiration for incoming apprentices is that they develop into valuable professionals for their future employers", shares Benjamin Geisser, Electrical Engineer from our Biomedical and Robotics Technologies Platform (BIROP), and most recently, a mentor to Pius Leserf, an apprentice at the platform. Learn how the experience has impacted both Pius and Benjamin from the interview piece 👇 BIROP is one of two core pillars of support that Wyss Zurich offers to incoming projects. Projects accelerating with us can tap on the expertise of platform to expedite their transfer to market. The team is made up of experienced professionals across a diverse range of core competences such as #ProductDevelopment, #Engineering, #IndustrialDesign, #Prototyping, design transfer and quality by design.

Every day is an opportunity to learn something new 💫 Two weeks ago, Wyss Zurich opened our doors to the current cohort of students at the BioEntrepreneurship & Innovation (BEI) program. The BEI program, established by the Institute for Regenerative Medicine (IREM), offers hands-on education and training for researchers in the field of #LifeScience, #MedTech, and #Pharma who aspire to become successful BioEntrepreneurs. Isabella Martini, Community Manager and Clara Cho, Communications Manager, had the opportunity to introduce these bright minds to Wyss Zurich and our work in supporting translational science. We talked about our #mission, our #purpose, the team and highlighted our #impact numbers. We also looked at the academic ecosystem map to identify our position within this vast #ecosystem. We are thankful to the students for bringing their inquisitiveness and questions to the visit and hope that all who participated brought back some valuable insights regarding the relationship between research / academia and startups / being an #entrepreneur.✨ Huges thanks to Jessica Plucain and Elias Meier for coordinating and collaborating on this visit🤗. #Bioentrepreneurship #AspiringEntrepreneurs #Startups #TranslationalResearch #InnovationInEducation #FutureLeaders

Last week, we had the pleasure of hosting the final workshop of the Venture Challenge @ ETH Zürich series organized by Venturelab✨ Opening the session, Raffael Kellner, Program Manager at Venturelab, briefly introduced the organisation and highlighted some of Venturelab's impact numbers. Our Community Manager, Isabella Martini then shared briefly about the work of our accelerator - Wyss Zurich. During this workshop, participants were introduced to what the perfect pitch looks like. Before we dived into the theory, four brave participants took the floor to introduce their projects and received feedback from the group. We were thrilled to see Gallus K., Business Development, from our current project, Tethys (Tethys Robotics), introduce not only their innovative underwater robot but also a sense of how the team would pitch / present themselves to investors / VCs. Referencing their slide deck, Gallus pointed out key characteristics, such as showing the impact of your solution contrasting with existing solutions in the market, that would make Tethys stand out. In the next part of the presentation, Nicholas James Eyring, Program Manager at Venture Kick shared with the participants on storytelling and how to win audience buy-in. The goal of a pitch? To convince X of Y. Two main points to think about: 🟢 Who buys what and why? 🟢 Build credibility Other key takeaways: 🟢 Stay simple 🟢 Be specific 🟢 Be authentic 🟢 Help us dream See some impressions below from the workshop🤗 #StartupWorkshops #PitchingExcellence #StorytellingSkills #EffectiveStorytelling #StartupJourney #PitchYourStartup